Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 31 out of 100. Brain scans and imaging

Topic: Amyloid, tau and blood-test diagnosis

Alzheimer's disease (AD) is a progressive brain disorder that leads to memory loss and a gradual decline in thinking and reasoning abilities. One of the major challenges in dealing with Alzheimer's is detecting it early and accurately using MRI brain scans. Traditional manual analysis of these scans can be slow, complex, and prone to human mistakes over the years, different machine learning (ML) models like Decision Tree, Random Forest, Logistic Regression, and K-Nearest Neighbors have been used to identify Alzheimer's. However, these models often face issues such as overfitting, lower accuracy, and weak performance when dealing with complex and high-dimensional MRI data.to overcome these limitations, the proposed approach uses SVM model for detecting and classifying Alzheimer's disease. The SVM model is well-suited for handling non-linear and complex data. It can effectively separate different disease categories by using advanced kernel functions and optimal hyperplane techniques. This leads to more precise and stable classification results, even with smaller datasets compared to existing ML models, the proposed SVM model achieves higher accuracy, sensitivity, and specificity, making it more dependable for automatic Alzheimer's detection. It not only reduces errors but also helps in identifying the disease at an early stage, which is crucial for better treatment and patient care. With 98.16% classification accuracy, it outperforms current architectures significantly in the Alzheimer Detection and Classification Using SVM.

Key findings

Why it matters

This study used a support vector machine model to detect and classify Alzheimer's disease from MRI brain scans, reporting 98.16% classification accuracy and better accuracy, sensitivity and specificity than other machine learning models. It is a diagnostic classification tool only and does not test any treatment, cure or prevention.

Study details

How this study scored 31/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 28 of the 89 points it could be judged on, which is 31 of 100. Total 31 of 100.28 of the 89 points we could judge = 31 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it. We have no data on journal's citation record, senior author's track record and institution's track record, so those were left out: it earned 28 of the 89 points we could judge it on, which is 31 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Zenodo (CERN European Organization for Nuclear Research))
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author B Reshma holds only 1 work(s), too few to judge a track record — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 28 / 89 Scored on 17 of 20 parts. We have no data for the rest, so they are left out: 28 of the 89 points we could judge it on is 31 out of 100.
Total 31 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Manogna, V., Durga, B., Sravani, P., Yamuna, N., & Reshma, B. (2026). Alzheimer Detection And Classification Using SVM. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20065683

Vancouver

Manogna V, Durga B, Sravani P, Yamuna N, Reshma B. Alzheimer Detection And Classification Using SVM. Zenodo (CERN European Organization for Nuclear Research). 2026. doi:10.5281/zenodo.20065683.

BibTeX

@article{manogna2026-3541ccba,
  author  = {Manogna, V and Durga, B and Sravani, P and Yamuna, N and Reshma, B},
  title   = {{Alzheimer Detection And Classification Using SVM}},
  journal = {Zenodo (CERN European Organization for Nuclear Research)},
  year    = {2026},
  doi     = {10.5281/zenodo.20065683},
  url     = {https://doi.org/10.5281/zenodo.20065683}
}

Related studies in Brain scans and imaging

Also in Brain scans and imaging

114 studies in the library are filed under Brain scans and imaging with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Brain scans and imaging hub.

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →